Long-term follow-up of Janus-kinase inhibitor and novel active disease biomarker in juvenile dermatomyositis. - Huang B; Wang X; Niu Y; Ding Y; Tan Q; Li Y; Liu Y; Chi Y; Wang Y; Zhou Z; Li J (Rheumatology (Oxford, England), 2023)